What are Intralesional drugs?
Intralesional drugs are products intended for administration within or introduced directly into a localized lesion. Healthcare teams may also search this route as lesion injection, intralesional medications, lesion-directed injectables, and within-lesion drugs. This category is most relevant for dermatology, oncology, podiatry, and office-procedure workflows where a lesion-specific injection route has been requested. Common product examples in this catalog include Betamethasone Acetate and Betamethasone Sodium Phosphate and Dexamethasone Sodium Phosphate. When sourcing intralesional medications, healthcare teams usually compare NDC, strength or concentration, dosage form, package configuration, and any route-specific storage or handling requirements.
Also searched as: lesion injection, intralesional medications, lesion-directed injectables, within-lesion drugs
Leading manufacturers in this category: Amneal Pharmaceuticals LLC (13), Pharmacia & Upjohn Company LLC (13), Eugia US LLC (7), and Mylan Institutional LLC (6).
